← All trials
NCT00561899
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2007
- Primary completion
- Feb 1, 2008
- Completion date
- Jun 1, 2008
- First posted
- —
- Last posted
- —
- Enrollment
- 1295
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- University of LondonLead sponsor
- Medical Research Council, The GambiaOverall official - principal investigator
- Medical Research CouncilOverall official - principal investigator
- Department of State for Health and Social Welfare, The GambiaCollaborator
- University of LondonReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.